Team-based learning course
The International Society on Thrombosis and Haemostasis (ISTH) has launched a new team-based learning course focused on bringing together early-career physicians from around the world to collaborate on complex cases in bleeding and clotting.
The course features three case modules on these topics:
- Bleeding in patients on antithrombotics
- Anticoagulation in patients with impaired kidney function
- Thromboprophylaxis in patients with thrombophilia
The course will accommodate three learning teams, each consisting of 10-15 students (45 total students maximum) and three facilitators (nine total facilitators), who will mentor the students. The virtual course lasts 12 weeks, April 5-June 26, with a final in-person meeting in Bangkok, Thailand at the ISTH 2024 Congress (virtual attendance also available). Learning teams will meet virtually at least once weekly, with a gap week between each module.
Students will be assigned three complex cases based on real patients. Over the next 12 weeks, they will work virtually with their peers and expert facilitators to diagnose and develop treatment plans. The final meeting will take place at the ISTH 2024 Congress in Bangkok, Thailand.
Students will be awarded a certificate upon successful completion of the course with 75% attendance.
Course learning objectives:
By the end of the course, the participants will be able to:
- Manage bleeding complications in patients on antithrombotic medications, by making evidence-based decisions taking into considerations the risk for continuing bleeding and thrombotic events
- Manage anticoagulants in patients with severely impaired kidney function and balance the benefits of anticoagulation with the bleeding risk associated with kidney failure
- Make decisions on thromboprophylaxis in patients with various types of thrombophilia depending on the individual thrombotic risk as comprised of thrombophilia and other risk factors.
Students should be early-career physicians with at least three years of experience in a center managing bleeding and/or thrombotic disorders.